These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29329022)

  • 1. Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study.
    Kudo D; Hayakawa M; Ono K; Yamakawa K
    Thromb Res; 2018 Mar; 163():22-29. PubMed ID: 29329022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
    Hayakawa M; Kudo D; Saito S; Uchino S; Yamakawa K; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
    Shock; 2016 Dec; 46(6):623-631. PubMed ID: 27548460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.
    Yamakawa K; Umemura Y; Hayakawa M; Kudo D; Sanui M; Takahashi H; Yoshikawa Y; Hamasaki T; Fujimi S;
    Crit Care; 2016 Jul; 20(1):229. PubMed ID: 27472991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yamakawa K; Ogura H; Fujimi S; Morikawa M; Ogawa Y; Mohri T; Nakamori Y; Inoue Y; Kuwagata Y; Tanaka H; Hamasaki T; Shimazu T
    Intensive Care Med; 2013 Apr; 39(4):644-52. PubMed ID: 23361628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation.
    Yamakawa K; Umemura Y; Murao S; Hayakawa M; Fujimi S
    Clin Appl Thromb Hemost; 2019; 25():1076029619835055. PubMed ID: 30841721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
    Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation.
    Iba T; Nagaoka I; Boulat M
    Thromb Res; 2013 May; 131(5):383-9. PubMed ID: 23566533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study.
    Umemura Y; Yamakawa K; Hayakawa M; Kudo D; Fujimi S
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):734-740. PubMed ID: 29471674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying Sepsis Populations Benefitting from Anticoagulant Therapy: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
    Yamakawa K; Gando S; Ogura H; Umemura Y; Kabata D; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
    Thromb Haemost; 2019 Nov; 119(11):1740-1751. PubMed ID: 31408900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan.
    Iba T; Gando S; Thachil J
    J Thromb Haemost; 2014 Jul; 12(7):1010-9. PubMed ID: 24801203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.
    Umemura Y; Yamakawa K; Ogura H; Yuhara H; Fujimi S
    J Thromb Haemost; 2016 Mar; 14(3):518-30. PubMed ID: 26670422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.
    Yamakawa K; Fujimi S; Mohri T; Matsuda H; Nakamori Y; Hirose T; Tasaki O; Ogura H; Kuwagata Y; Hamasaki T; Shimazu T
    Crit Care; 2011; 15(3):R123. PubMed ID: 21569368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Saitoh D; Gando S; Thachil J
    Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.
    Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
    BMC Cancer; 2020 Sep; 20(1):867. PubMed ID: 32907555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis-related coagulopathy treatment based on the disseminated intravascular coagulation diagnostic criteria: a post-hoc analysis of a prospective multicenter observational study.
    Wada T; Yamakawa K; Kabata D; Abe T; Fujishima S; Kushimoto S; Mayumi T; Ogura H; Saitoh D; Shiraishi A; Otomo Y; Gando S;
    J Intensive Care; 2023 Mar; 11(1):8. PubMed ID: 36872342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.